The reason for this is thought to be due to a weaker anti-tumor immune response owing to immunosuppressive cytokines, such as TGF-β and T cell dysfunction in the tumor microenvironment and selection pressure, leading to altered immune checkpoint expression on cancerous cells [6,79]. This evidence concerns the gene TGFB1 and neoplasm.